Pristiq Extended-Release 50 mg/1 (Desvenlafaxine Succinate TABLET, EXTENDED RELEASE) 50 mg/1

Pristiq Extended-Release 50 mg/1 is a prescription medication used to manage major depressive disorder. This extended-release tablet contains desvenlafaxine succinate, offering a convenient once-daily option for those seeking relief from depressive symptoms.

Strength

50 mg/1

Pack Size

100 BLISTER PACK in 1 CARTON (0008-1211-50) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Manufacturer / TM Owner

Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pristiq Extended-Release 50 mg/1 is primarily used to treat major depressive disorder. Desvenlafaxine succinate, the active ingredient, works by affecting the balance of certain natural substances in the brain. This medication is designed for oral administration and is often considered for individuals who require a consistent, extended-release formulation to manage their symptoms throughout the day.

Side Effects

Common effects of Pristiq Extended-Release 50 mg/1 may include nausea, dizziness, and fatigue. Some users also report dry mouth, constipation, and insomnia. These effects can vary in intensity and duration, and not everyone will experience them. It's important to consult with a healthcare provider if any effects are persistent or concerning.

Precautions & Warnings

Pristiq Extended-Release 50 mg/1 should be handled with care. Store the medication in a cool, dry place away from direct sunlight and out of reach of children. Do not crush or chew the extended-release tablets, as this can alter their effectiveness. Always follow the guidance provided by your healthcare provider regarding the use of this medication.

Avoid Interactions

Pristiq Extended-Release 50 mg/1 may interact with other medications, including those that affect serotonin levels. Alcohol and certain over-the-counter drugs can also interact with desvenlafaxine succinate. It's crucial to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Pristiq Extended-Release 50 mg/1 is used to manage major depressive disorder. It helps to balance certain natural substances in the brain to alleviate depressive symptoms.

Pristiq Extended-Release 50 mg/1 should be taken orally, typically once daily. Do not crush or chew the tablets, as they are designed for extended-release.

Common side effects may include nausea, dizziness, fatigue, dry mouth, constipation, and insomnia. These effects can vary in intensity and duration.

It's generally advised to avoid alcohol while taking Pristiq Extended-Release 50 mg/1, as it may interact with the medication and cause unwanted effects.

Store Pristiq Extended-Release 50 mg/1 in a cool, dry place away from direct sunlight and out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.